
Researchers evaluate potential reasons why HIV some drug combinations are more effective in certain patients.

Researchers evaluate potential reasons why HIV some drug combinations are more effective in certain patients.

DEA campaign called Operation Pilluted targets illegally diverted prescription medications.

Legislators are becoming more informed about DIR fees and their harms on Medicare beneficiaries and specialty pharmacies.

Many cancer drug approvals based on indirect measures, study finds.

An estimated 75% of patients with multiple sclerosis report fatigue among their most disabling disease symptoms.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses the importance of pharmacy residency programs.

A lack of biomarkers can result in a delay in multiple sclerosis diagnosis and treatment.

Top news of the day from across the healthcare landscape.

Current guidelines for treating children with HIV recommend regular medical visits for the first 2 years after care initiation.

Non-adherence to medication regimens is estimated to cost approximately $290 billion dollars in unnecessary medical expenses.

Cancer care at hospitals is significantly more expensive than at community oncology clinics.

Levels of certain bacteria and fungi appear to be higher among individuals with Crohn’s disease.

Two-drug combination of injectable, long-acting cabotegravir plus rilpivirine monthly or bi-monthly showed comparable efficacy to a daily 3-drug oral therapy at maintaining HIV-1 viral suppression.

Top news of the day from across the healthcare landscape.

Researchers continue to focus on developing an 8-week treatment regimen for hepatitis C virus.

Patients with ovarian cancer often face complex burdens that go beyond just medication.

A synthetic particle awakens dormant HIV cells then knocks them out.

The grant from the National Multiple Sclerosis Society aims to support the development of a potential oral treatment for progressive forms of MS.

An oncoprotein produced by the human papillomavirus results in cells that proliferate and do not die.

Moses Zoanna, CEO of Compliance Meds Technologies, discusses the impact of mobile health.

A biochip may be able to detect HIV in a drop of blood and display the results within 10 seconds.

Top news of the day from across the healthcare landscape.

Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.

Mastectomy rates increased after actress Angelia Jolie announced her procedure.

Top news from across the healthcare landscape.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top news of the week from Specialty Pharmacy Times.

Spending for adalimumab has tripled from 2012 from $4.5 billion.

Pharmacists who are unfamiliar with either the principles of infectious disease or HIV may miss errors.

Mass spectrometry device rapidly identifies molecular profile of cancerous tissue.